
Centene (CNC) Stock Forecast & Price Target
Centene (CNC) Analyst Ratings
Bulls say
Centene's membership base of 22 million medical members, predominantly in Medicaid, positions the company favorably in the managed care sector, particularly as government-sponsored healthcare remains a critical area of growth. The positive indicators surrounding Medicare Advantage (MA) and Medicare Part D (PDP) suggest confidence in improving financial performance, potentially providing a boost to expectations in the upcoming quarters. Additionally, Centene's strategic adjustments, such as the incorporation of increased conservatism on trends within their Medicaid operations, may effectively mitigate some of the pressures they are currently facing, enhancing the long-term outlook for the organization.
Bears say
Centene faces significant financial challenges, highlighted by an anticipated risk adjustment shortfall of $1.8 billion to $2.75 billion compared to prior guidance, which could undermine profitability. Additionally, ongoing pressures on Medicaid margin utilization and the potential deterioration of marketplace risk scores through 2026 further complicate the company’s financial outlook. Moreover, a substantial marketplace medical loss ratio (MLR) miss of 530 basis points in the first quarter of 2025 has contributed to investor caution regarding the company’s future performance.
This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.
Centene (CNC) Analyst Forecast & Price Prediction
Start investing in Centene (CNC)
Order type
Buy in
Order amount
Est. shares
0 shares